AGL-2263 is a novel insulin receptor inhibitor.
For research use only. We do not sell to patients.
| Name | AGL-2263 |
|---|---|
| Iupac Chemical Name | (E)-2-(3,4-Dihydroxybenzoyl)-3-(2-oxo-3H-1,3-benzoxazol-5-yl)prop-2-enenitrile |
| Synonyms | AGL-2263 |
| Molecular Formula | C17H10N2O5 |
| Molecular Weight | 322.276 |
| Smile | N#C/C(C(C1=CC=C(O)C(O)=C1)=O)=C\C2=CC=C(OC(N3)=O)C3=C2 |
| InChiKey | IUGRBTCJEYEDIY-VZUCSPMQSA-N |
| InChi | InChI=1S/C17H10N2O5/c18-8-11(16(22)10-2-3-13(20)14(21)7-10)5-9-1-4-15-12(6-9)19-17(23)24-15/h1-7,20-21H,(H,19,23)/b11-5+ |
| CAS Number | 638213-98-6 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |